These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 8504621)

  • 1. Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.
    Reetze-Bonorden P; Böhler J; Keller E
    Clin Pharmacokinet; 1993 May; 24(5):362-79. PubMed ID: 8504621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)].
    Pittrow L; Penk A
    Mycoses; 1998; 41 Suppl 2():86-8. PubMed ID: 10085695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD).
    Pittrow L; Penk A
    Mycoses; 1999 Apr; 42(1-2):17-9. PubMed ID: 10394842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics during continuous haemofiltration.
    Bressolle F; Kinowski JM; de la Coussaye JE; Wynn N; Eledjam JJ; Galtier M
    Clin Pharmacokinet; 1994 Jun; 26(6):457-71. PubMed ID: 8070219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug dosing during continuous arteriovenous hemofiltration.
    Bickley SK
    Clin Pharm; 1988 Mar; 7(3):198-206. PubMed ID: 3281789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.
    Joos B; Schmidli M; Keusch G
    Nephrol Dial Transplant; 1996 Aug; 11(8):1582-5. PubMed ID: 8856215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V; Verbeelen D; Maes V; Sennesael J
    Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients.
    Keller E; Böhler J; Busse-Grawitz A; Reetze-Bonorden P; Krumme B; Schollmeyer P
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S20-3. PubMed ID: 7781200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage.
    Böhler J; Donauer J; Keller F
    Kidney Int Suppl; 1999 Nov; (72):S24-8. PubMed ID: 10560800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.
    Davies SP; Azadian BS; Kox WJ; Brown EA
    Nephrol Dial Transplant; 1992; 7(8):848-54. PubMed ID: 1325620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.
    Paton TW; Cornish WR; Manuel MA; Hardy BG
    Clin Pharmacokinet; 1985; 10(5):404-25. PubMed ID: 3899455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure.
    Valtonen M; Tiula E; Neuvonen PJ
    J Antimicrob Chemother; 1997 Nov; 40(5):695-700. PubMed ID: 9421318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.
    Keller E; Fecht H; Böhler J; Schollmeyer P
    Nephrol Dial Transplant; 1989; 4(7):640-5. PubMed ID: 2510062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.
    Lee CS; Marbury TC
    Clin Pharmacokinet; 1984; 9(1):42-66. PubMed ID: 6362952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous arteriovenous haemodialysis and haemofiltration in intensive care acute renal failure patients.
    Alarabi AA; Taube A; Danielson BG; Wikström B
    Int Urol Nephrol; 1992; 24(6):657-64. PubMed ID: 1289277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of antitubercular agents for disseminated Mycobacterium tuberculosis during intermittent haemodialysis and continuous venovenous haemofiltration.
    Sin JH; Elshaboury RH; Hurtado RM; Letourneau AR; Gandhi RG
    J Clin Pharm Ther; 2018 Apr; 43(2):291-295. PubMed ID: 28895161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysis.
    Boulieu R; Bastien O; Bleyzac N
    Ther Drug Monit; 1993 Apr; 15(2):105-7. PubMed ID: 8389067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.